 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
DVC1.03-HMO-CTIL
NCT00312819
|
|
| |
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
|
|
|
|
Phase III, Phase II
|
|
|
|
AMT/P2CA/001
LC003AURON2005, NCT00332280
|
|
| |
Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IV
|
|
|
|
Phase III, Phase II
|
|
|
|
CT 07-03
NCT00516685
|
|
| |
Complementary Treatment of PG2 to Improve Clinical Benefit Response and Quality of Life in Fatigue
|
|
|
|
Phase III, Phase II
|
|
|
|
PH-CP010
NCT00518869
|
|
| |
Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
Hamamatsu 18-66
NCT00752115
|
|
| |
Chemotherapy With or Without Radiation Therapy Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
|
|
|
|
Phase III
|
|
|
|
SWS-SAKK-16/00
EU-20138, NCT00030771
|
|
| |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
|
|
|
|
Phase III
|
|
|
|
RTOG-0320
RTOG-0320, NCT00096265
|
|
| |
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
|
|
|
|
Phase III
|
|
|
|
CP02-0452
NCT00095199
|
|
| |
Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
|
|
|
|
Phase III
|
|
|
|
ACOSOG-Z4032
ACOSOG-Z4032, NCT00107172
|
|
| |
Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
|
|
|
|
Phase III
|
|
|
|
CRUK-BTOG2-LU3005
EU-20510, NCT00112710
|
|
